This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Mouse Anti-Rat IgM µ chain Antibody, Cy5 conjugate
catalog :
MAB507S
quantity :
0.1 mg
clonality :
monoclonal
host :
mouse
conjugate :
Cy5
application :
immunocytochemistry
product information
Catalog Number :
MAB507S
Subcategory :
Secondary & Control Antibodies
Product Name :
Mouse Anti-Rat IgM µ chain Antibody, Cy5 conjugate
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Host Name :
Mouse
Antigen :
Mouse Rat IgM µ chain
Conjugate :
Cy5
Product Description :
Mouse Anti-Rat IgM µ chain Antibody, Cy5 conjugate
Cross Reactivity :
Rat
Background :
IgM constitutes about 10% of serum immunoglobulins. IgM antibody is prominent in early immune responses to most antigens and predominates in certain antibody responses such as 'natural' blood group antibodies. IgM (with IgD) is the major immunoglobulin expressed on the surface of B cells. The gene for the mu constant region contains four domains separated by short intervening sequences.
Immunogen :
Prepared from rat IgM µ chain.
Specificity :
The antibody reacts with the µ heavy chain (Fc) of rat IgM.
Package Size :
0.1 mg
Uses :
ELISA;Immunofluorescence
Storage :
Maintain refrigerated at 2°-8°C under sterile conditions for up to twelve months from date of receipt. Do not freeze.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments